Cargando…

Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance

Escherichia coli isolates from inflammatory bowel disease (IBD) patients are often multidrug resistant, including to streptomycin. Streptomycin resistance (Str(R)) mutations can alter bacterial behavior, which may influence intestinal disease. We generated a spontaneous Str(R) strain of the intestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Lacey R., Miller, Claire M., Jeyachandran, Joanna N., Li, Chuang, Simpson, Kenneth W., Arthur, Janelle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269711/
https://www.ncbi.nlm.nih.gov/pubmed/37184392
http://dx.doi.org/10.1128/spectrum.03500-22
_version_ 1785059231702974464
author Lopez, Lacey R.
Miller, Claire M.
Jeyachandran, Joanna N.
Li, Chuang
Simpson, Kenneth W.
Arthur, Janelle C.
author_facet Lopez, Lacey R.
Miller, Claire M.
Jeyachandran, Joanna N.
Li, Chuang
Simpson, Kenneth W.
Arthur, Janelle C.
author_sort Lopez, Lacey R.
collection PubMed
description Escherichia coli isolates from inflammatory bowel disease (IBD) patients are often multidrug resistant, including to streptomycin. Streptomycin resistance (Str(R)) mutations can alter bacterial behavior, which may influence intestinal disease. We generated a spontaneous Str(R) strain of the intestinal adherent-invasive E. coli (AIEC) strain NC101. Whole-genome sequencing revealed a single missense mutation in rpsL that commonly confers Str(R), rpsL-K43N. Str(R) NC101 exhibited a striking loss of aggregation and significantly increased motility, behaviors that can impact host-microbe interactions. Behavioral changes were associated with reduced transcription of csgA, encoding the biofilm component curli, and increased transcription of fliC, encoding flagellin. Scanning electron microscopy (SEM) detailed morphologic changes consistent with the observed alterations in multicellular behavior. Because intestinal E. coli isolates exhibit remarkable strain-specific differences, we generated spontaneous Str(R) mutants of 10 clinical E. coli phylotype B2 strains from patients with IBD, colorectal cancer, and urinary tract infection. Out of these 10 Str(R) clinical strains, two had altered colony morphology on Congo red agar (suggesting changes in extracellular products), and three had significant changes in motility. These changes were not associated with a particular rpsL mutation nor with the presence of virulence genes encoding the inflammation-associated E. coli metabolites yersiniabactin or colibactin. We conclude that common mutations in rpsL, which confer Str(R), can differentially alter disease-associated phenotypes across intestinal E. coli strains. These findings highlight the heterogeneity among seemingly similar intestinal E. coli strains and reveal the need to carefully study the strain-specific effects of antibiotic resistance mutations, particularly when using these mutations during strain selection studies. IMPORTANCE We demonstrate that Str(R), commonly acquired through a single point mutation in rpsL (a gene encoding part of the 30S bacterial ribosome), strikingly alters the morphology and behavior of a key intestinal AIEC strain, NC101. These changes include remarkably diminished aggregation and significantly increased motility, traits that are linked to AIEC-defining features and disease development. Phenotypic changes were heterogeneous among other Str(R) clinical E. coli strains, underscoring the need to evaluate the strain-specific effects of commonly acquired antibiotic resistance mutations. This is important, as the results of studies using mutant Str(R) Enterobacteriaceae strains (e.g., for cloning or in vivo selection) may be confounded beyond our demonstrated effects. Long term, these findings can help researchers better distinguish the contribution of specific E. coli traits to functional changes in the microbiota. Evaluating these strain-level differences could provide insight into the diversity of IBD symptoms and lead to improved therapies for microbiota-driven intestinal disorders.
format Online
Article
Text
id pubmed-10269711
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-102697112023-06-16 Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance Lopez, Lacey R. Miller, Claire M. Jeyachandran, Joanna N. Li, Chuang Simpson, Kenneth W. Arthur, Janelle C. Microbiol Spectr Observation Escherichia coli isolates from inflammatory bowel disease (IBD) patients are often multidrug resistant, including to streptomycin. Streptomycin resistance (Str(R)) mutations can alter bacterial behavior, which may influence intestinal disease. We generated a spontaneous Str(R) strain of the intestinal adherent-invasive E. coli (AIEC) strain NC101. Whole-genome sequencing revealed a single missense mutation in rpsL that commonly confers Str(R), rpsL-K43N. Str(R) NC101 exhibited a striking loss of aggregation and significantly increased motility, behaviors that can impact host-microbe interactions. Behavioral changes were associated with reduced transcription of csgA, encoding the biofilm component curli, and increased transcription of fliC, encoding flagellin. Scanning electron microscopy (SEM) detailed morphologic changes consistent with the observed alterations in multicellular behavior. Because intestinal E. coli isolates exhibit remarkable strain-specific differences, we generated spontaneous Str(R) mutants of 10 clinical E. coli phylotype B2 strains from patients with IBD, colorectal cancer, and urinary tract infection. Out of these 10 Str(R) clinical strains, two had altered colony morphology on Congo red agar (suggesting changes in extracellular products), and three had significant changes in motility. These changes were not associated with a particular rpsL mutation nor with the presence of virulence genes encoding the inflammation-associated E. coli metabolites yersiniabactin or colibactin. We conclude that common mutations in rpsL, which confer Str(R), can differentially alter disease-associated phenotypes across intestinal E. coli strains. These findings highlight the heterogeneity among seemingly similar intestinal E. coli strains and reveal the need to carefully study the strain-specific effects of antibiotic resistance mutations, particularly when using these mutations during strain selection studies. IMPORTANCE We demonstrate that Str(R), commonly acquired through a single point mutation in rpsL (a gene encoding part of the 30S bacterial ribosome), strikingly alters the morphology and behavior of a key intestinal AIEC strain, NC101. These changes include remarkably diminished aggregation and significantly increased motility, traits that are linked to AIEC-defining features and disease development. Phenotypic changes were heterogeneous among other Str(R) clinical E. coli strains, underscoring the need to evaluate the strain-specific effects of commonly acquired antibiotic resistance mutations. This is important, as the results of studies using mutant Str(R) Enterobacteriaceae strains (e.g., for cloning or in vivo selection) may be confounded beyond our demonstrated effects. Long term, these findings can help researchers better distinguish the contribution of specific E. coli traits to functional changes in the microbiota. Evaluating these strain-level differences could provide insight into the diversity of IBD symptoms and lead to improved therapies for microbiota-driven intestinal disorders. American Society for Microbiology 2023-05-15 /pmc/articles/PMC10269711/ /pubmed/37184392 http://dx.doi.org/10.1128/spectrum.03500-22 Text en Copyright © 2023 Lopez et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Observation
Lopez, Lacey R.
Miller, Claire M.
Jeyachandran, Joanna N.
Li, Chuang
Simpson, Kenneth W.
Arthur, Janelle C.
Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title_full Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title_fullStr Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title_full_unstemmed Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title_short Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
title_sort heterogeneity among clinical intestinal escherichia coli isolates upon acquired streptomycin resistance
topic Observation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269711/
https://www.ncbi.nlm.nih.gov/pubmed/37184392
http://dx.doi.org/10.1128/spectrum.03500-22
work_keys_str_mv AT lopezlaceyr heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance
AT millerclairem heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance
AT jeyachandranjoannan heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance
AT lichuang heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance
AT simpsonkennethw heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance
AT arthurjanellec heterogeneityamongclinicalintestinalescherichiacoliisolatesuponacquiredstreptomycinresistance